NICOLE MADERA: Open Payments
NPI 1841229937 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$50,331 in 225 payments from 20 companies in 2025. Trend: 2023 $27,040 · 2024 $29,072 · 2025 $50,331
Consulting: $31,270Travel & lodging: $8,709Speaker / faculty: $6,050Food & beverage: $4,242Education: $61
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 75 | $30,552 |
| Lilly USA, LLC | 22 | $9,571 |
| UCB, Inc. | 38 | $7,420 |
| ABBVIE INC. | 17 | $797 |
| Kowa Pharmaceuticals America, Inc. | 1 | $350 |
| Janssen Biotech, Inc. | 9 | $253 |
| GENZYME CORPORATION | 6 | $239 |
| Novartis Pharmaceuticals Corporation | 14 | $227 |
| Amgen Inc. | 4 | $179 |
| LEO Pharma Inc. | 5 | $161 |
Products named: ZORYVE, Bimzelx, TALTZ, EBGLYSS, DUPIXENT, TREMFYA, SKYRIZI, COSENTYX.
Industry payments across AZ — which companies pay providers there.
